Celldex Therapeutics reported $4.9M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
AbbVie USD 70.82B 2.04B Jun/2026
Agenus USD 35.54M 2.34M Mar/2025
Amgen USD 57.3B 19M Jun/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Celldex Therapeutics USD 4.9M 3M Jun/2026
Glaxosmithkline GBP 23.7B 4.65B Sep/2026
Nektar Therapeutics USD 0 0 Jun/2022
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 62.67B 523M Sep/2026
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025